Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents

References

• Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009;29:938–46.
   PubMed Web of Science ®Google Scholar
• Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagaya H, Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000;12:635–40.
   PubMed Web of Science ®Google Scholar
• Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lee YT, Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc 2001;53:438–42.
   PubMed Web of Science ®Google Scholar
• Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JB. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999;94:1834–40.
   PubMed Web of Science ®Google Scholar
• Jang HJ, Choi MH, Shin WG, Kim KH, Chung YW, Kim KO, Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study. Dig Dis Sci 2008;53:1527–31.
   PubMed Web of Science ®Google Scholar
• Kim JI, Kim SG, Kim N, Kim JG, Shin SJ, Kim SW, Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol 2009;21:787–93.
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Pajares JM. Helicobacter pylori and bleeding peptic ulcer: what is the prevalence of the infection in patients with this complication? Scand J Gastroenterol 2003;38:2–9.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9:59–69.
   PubMed Web of Science ®Google Scholar
• Pilotto A, Leandro G, Di Mario F, Franceschi M, Bozzola L, Valerio G. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997;42:586–91.
   PubMed Web of Science ®Google Scholar
• Adamopoulos AB, Efstathiou SP, Tsioulos DI, Tzamouranis DG, Tsiakou AG, Tiniakos D, Bleeding duodenal ulcer: comparison between Helicobacter pylori positive and Helicobacter pylori negative bleeders. Dig Liver Dis 2004;36:13–20.
   PubMedGoogle Scholar
• Yeomans ND, Naesdal J. Systematic review: ulcer definition in NSAID ulcer prevention trials. Aliment Pharmacol Ther 2008;27:465–72.
   PubMed Web of Science ®Google Scholar
• Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333–40.
   PubMed Web of Science ®Google Scholar
• Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2–17.
   PubMed Web of Science ®Google Scholar
• Hung LC, Ching JY, Sung JJ, To KF, Hui AJ, Wong VW, Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology 2005;128:1845–50.
   PubMed Web of Science ®Google Scholar
• Vaira D, Menegatti M, Miglioli M. What is the role of Helicobacter pylori in complicated ulcer disease? Gastroenterology 1997;113:S78–84.
   Web of Science ®Google Scholar
• Wong GL, Wong VW, Chan Y, Ching JY, Au K, Hui AJ, High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology 2009;137:525–31.
   PubMed Web of Science ®Google Scholar
• Labenz J, Peitz U, Kohl H, Kaiser J, Malfertheiner P, Hackelsberger A, Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study. Ital J Gastroenterol Hepatol 1999;31:110–15.
   PubMed Web of Science ®Google Scholar
• Lee JM, Breslin NP, Fallon C, O'Morain CA. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. Am J Gastroenterol 2000;95:1166–70.
   PubMed Web of Science ®Google Scholar
• Tu TC, Lee CL, Wu CH, Chen TK, Chan CC, Huang SH, Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers. Gastrointest Endosc 1999;49:302–6.
   PubMed Web of Science ®Google Scholar
• Leung WK, Sung JJ, Siu KL, Chan FK, Ling TK, Cheng AF. False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood. Am J Gastroenterol 1998;93:1914–18.
   PubMed Web of Science ®Google Scholar
• Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002;359:9–13.
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Romano M. Helicobacter pylori and non-steroidal anti-inflammatory drugs. Dig Liver Dis 2000;32:S211–13.
   PubMedGoogle Scholar
• Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14–22.
   PubMed Web of Science ®Google Scholar
• Ng TM, Fock KM, Khor JL, Teo EK, Sim CS, Tan AL, Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer. Aliment Pharmacol Ther 2000;14:203–9.
   PubMed Web of Science ®Google Scholar
• Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology 1999;116:1305–9.
   PubMed Web of Science ®Google Scholar
• Santolaria S, Lanas A, Benito R, Perez-Aisa M, Montoro M, Sainz R. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. Aliment Pharmacol Ther 1999;13:1511–18.
   PubMed Web of Science ®Google Scholar
• Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044–54.
   PubMed Web of Science ®Google Scholar
• Fletcher EH, Johnston DE, Fisher CR, Koerner RJ, Newton JL, Gray CS. Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin. Aliment Pharmacol Ther 2010;32:831–9.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Iwakiri R, Hara M, Ootani H, Shimoda R, Tsunada S, Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. J Gastroenterol 2009;44:912–18.
   PubMed Web of Science ®Google Scholar
• Nakashima S, Arai S, Mizuno Y, Yoshino K, Ando S, Nakamura Y, A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2005;21:60–6.
   PubMed Web of Science ®Google Scholar
• Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sainz R. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002;16:779–86.
   PubMed Web of Science ®Google Scholar
• Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993;34:748–51.
   PubMed Web of Science ®Google Scholar
• Feldman M, Cryer B, Mallat D, Go MF. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial. Am J Gastroenterol 2001;96:1751–7.
   PubMed Web of Science ®Google Scholar